Colorectal Cancer Metastatic dMMR Immunotherapy (COMMIT) study: A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo (FFX/bev) in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) or microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC) NRG-GI004/SWOG-S1610
However, the efferocytosis of SARS-CoV-2-infected ACs by macrophages inhibits many efferocytic receptors, such as CD36, V5 integrin (ITGB5), and T cell immunoglobulin mucin receptor 4 (TIM4), as well as MER proto-oncogene tyrosine kinase (MERTK)
Any time people lose weight, they lose both fat and muscle, and this can be substantial when there is dramatic weight loss. Is access improving for weight-loss drugs like retatrutide
Clip Express Sales at 866-638-1908 or [email protected] Technical Support at 888-437-3244 or [email protected]
Development of a universal nanobody-binding Fab module for fiducial-assisted cryo-EM studies of membrane proteins